Zaretsky I, Atrakchi O, Mazor RD, Stoler-Barak L, Biram A, Feigelson SW, Gitlin AD, Engelhardt B, Shulman Z.
2017.
ICAMs support B cell interactions with T follicular helper cells and promote clonal selection.. J Exp Med. 214(11):3435-3448.
Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, Albright A, Cheng JD, S Kang P, Shankaran V et al..
2017.
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.. J Clin Invest. 127(8):2930-2940.
Goswami I, Coutermarsh-Ott S, Morrison RG, Allen IC, Davalos RV, Verbridge SS, Bickford LR.
2017.
Irreversible electroporation inhibits pro-cancer inflammatory signaling in triple negative breast cancer cells.. Bioelectrochemistry. 113:42-50.
DeBerge M, Yeap XYi, Dehn S, Zhang S, Grigoryeva L, Misener S, Procissi D, Zhou X, Lee DC, Muller WA et al..
2017.
MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.. Circ Res. 121(8):930-940.
Wickersham M, Wachtel S, Lung TWong Fok, Soong G, Jacquet R, Richardson A, Parker D, Prince A.
2017.
Metabolic Stress Drives Keratinocyte Defenses against Staphylococcus aureus Infection.. Cell Rep. 18(11):2742-2751.
Theodosakis N, Micevic G, Langdon CG, Ventura A, Means R, Stern DF, Bosenberg MW.
2017.
p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis.. J Invest Dermatol. 137(10):2187-2196.
Bhattacharya S, Yin J, Winborn CS, Zhang Q, Yue J, Chaum E.
2017.
Prominin-1 Is a Novel Regulator of Autophagy in the Human Retinal Pigment Epithelium.. Invest Ophthalmol Vis Sci. 58(4):2366-2387.
Beavers WN, Rose KL, Galligan JJ, Mitchener MM, Rouzer CA, Tallman KA, Lamberson CR, Wang X, Hill S, Ivanova PT et al..
2017.
Protein Modification by Endogenously Generated Lipid Electrophiles: Mitochondria as the Source and Target.. ACS Chem Biol. 12(8):2062-2069.
Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, Beqiri M, Sproesser K, Brafford PA, Xiao M et al..
2017.
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.. Nature. 546(7658):431-435.
Peterson LW, Philip NH, DeLaney A, Wynosky-Dolfi MA, Asklof K, Gray F, Choa R, Bjanes E, Buza EL, Hu B et al..
2017.
RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense.. J Exp Med. 214(11):3171-3182.